The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
The histamine H3receptor: an attractive target for the treatment of cognitive disorders
Open accessAbstract
The histamine H 3 receptor, first described in 1983 as a histamine autoreceptor and later shown to also function as a heteroreceptor that regulates the release of other neurotransmitters, has been the focus of research by numerous laboratories as it represents an attractive drug target for a number of indications including cognition. The purpose of this review is to acquaint the reader with the current understanding of H 3 receptor localization and function as a modulator of neurotransmitter release and its effects on cognitive processes, as well as to provide an update on selected H 3 antagonists in various states of preclinical and clinical advancement. Blockade of centrally localized H 3 receptors by selective H 3 receptor antagonists has been shown to enhance the release of neurotransmitters such as histamine, ACh, dopamine and norepinephrine, among others, which play important roles in cognitive processes. The cognitive‐enhancing effects of H 3 antagonists across multiple cognitive domains in a wide number of preclinical cognition models also bolster confidence in this therapeutic approach for the treatment of attention deficit hyperactivity disorder, Alzheimer's disease and schizophrenia. However, although a number of clinical studies examining the efficacy of H 3 receptor antagonists for a variety of cognitive disorders are currently underway, no clinical proof of concept for an H 3 receptor antagonist has been reported to date. The discovery of effective H 3 antagonists as therapeutic agents for the novel treatment of cognitive disorders will only be accomplished through continued research efforts that further our insights into the functions of the H 3 receptor. British Journal of Pharmacology(2008)154, 1166–1181; doi:10.1038/bjp.2008.147; published online 12 May 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
Arrang, J.-M., Garbarg, M., & Schwartz, J.-C. (1983) · Nature · doi:10.1038/302832a0 · Cited by 1,575
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
Robbins, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1154-7 · Cited by 1,282
MISHKIN, M. (1978) · Nature · doi:10.1038/273297a0 · Cited by 1,196
Cloning and Functional Expression of the Human Histamine H3Receptor
Lovenberg, T. W., Roland, B. L., Wilson, S. J., Jiang, X., Pyati, J., Huvar, A., Jackson, M. R., & Erlander, M. G. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.6.1101 · Cited by 696
The histamine H3 receptor: from gene cloning to H3 receptor drugs
Leurs, R., Bakker, R. A., Timmerman, H., & de Esch, I. J. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1631 · Cited by 485
High constitutive activity of native H3 receptors regulates histamine neurons in brain
Morisset, S., Rouleau, A., Ligneau, X., Gbahou, F., Tardivel-Lacombe, J., Stark, H., Schunack, W., Ganellin, C. R., & Arrang, J.-M. (2000) · Nature · doi:10.1038/35048583 · Cited by 461
A detailed mapping of the histamine H3 receptor and its gene transcripts in rat brain
Pillot, C., Heron, A., Cochois, V, Tardivel-Lacombe, J., Ligneau, X., Schwartz, J.-C., & Arrang, J.-M. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00135-5 · Cited by 344
Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors
Schlicker, E., Fink, K., Detzner, M., & G�thert, M. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244933 · Cited by 339
Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex
Schlicker, E., Betz, R., & G�thert, M. (1988) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00182737 · Cited by 311
Medhurst, A. D., Atkins, A. R., Beresford, I. J., Brackenborough, K., Briggs, M. A., Calver, A. R., Cilia, J., Cluderay, J. E., Crook, B., Davis, J. B., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120311 · Cited by 301
Identification of Rat H3 Receptor Isoforms with Different Brain Expression and Signaling Properties
Drutel, G., Peitsaro, N., Karlstedt, K., Wieland, K., Smit, M. J., Timmerman, H., Panula, P., & Leurs, R. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12349-8 · Cited by 288
Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates
Martinez-Mir, M. I., Pollard, H., Moreau, J., Arrang, J. M., Ruat, M., Traiffort, E., Schwartz, J. C., & Palacios, J. M. (1990) · Brain Research · doi:10.1016/0006-8993(90)91240-h · Cited by 265
Fox, G. B., Esbenshade, T. A., Pan, J. B., Radek, R. J., Krueger, K. M., Yao, B. B., Browman, K. E., Buckley, M. J., Ballard, M. E., Komater, V. A., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078402 · Cited by 262
Self-citationThe histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders
Passani, M. B., Lin, J.-S., Hancock, A., Crochet, S., & Blandina, P. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.10.003 · Cited by 255
Animal models of attention-deficit hyperactivity disorder.
Davids, E., Zhang, K., Tarazi, F. I., & Baldessarini, R. J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00274-6 · Cited by 250
Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors
Schlicker, E., Fink, K., Hinterthaner, M., & G�thert, M. (1989) · Naunyn-Schmiedebergs Archives of Pharmacology · doi:10.1007/bf00717738 · Cited by 250
Ligneau, X., Perrin, D., Landais, L., Camelin, J.-C., Calmels, T., Berrebi‐Bertrand, I., Lecomte, J., Parmentier, R., Anaclet, C., Lin, J., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111039 · Cited by 245
Neurochemical and Behavioral Effects of Ciproxifan, A Potent Histamine H3-Receptor Antagonist
Ligneau, X., Lin, J.-S., Vanni-Mercier, G., Jouvet, M., Muir, J. L., Ganellin, C. R., Stark, H., Elz, S., Schunack, W., & Schwartz, J.-C. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37840-1 · Cited by 242
Blandina, P., Giorgetti, M., Bartolini, L., Cecchi, M., Timmerman, H., Leurs, R., Pepeu, G., & Giovannini, M. G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16086.x · Cited by 233
Behavioral Characterization of Mice Lacking Histamine H3 Receptors
Toyota, H., Dugovic, C., Koehl, M., Laposky, A. D., Weber, C., Ngo, K., Wu, Y., Lee, D. H., Yanai, K., Sakurai, E., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.389 · Cited by 226
Keynote review: Histamine H3 receptor antagonists reach out for the clinic
Celanire, S., Wijtmans, M., Talaga, P., Leurs, R., & de Esch, I. J. P. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03625-1 · Cited by 210
Histamine H3 Receptor Antagonists: Preclinical Promise for Treating Obesity and Cognitive Disorders
Esbenshade, T. A. (2006) · Molecular Interventions · doi:10.1124/mi.6.2.5 · Cited by 194
Self-citationHuang, Z.-L., Mochizuki, T., Qu, W.-M., Hong, Z.-Y., Watanabe, T., Urade, Y., & Hayaishi, O. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600451103 · Cited by 184
Cloning of Rat Histamine H3 Receptor Reveals Distinct Species Pharmacological Profiles
Lovenberg, T. W., Pyati, J., Chang, H., Wilson, S. J., & Erlander, M. G. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39297-3 · Cited by 184
Neuronal histamine deficit in Alzheimer's disease
Panula, P., Rinne, J., Kuokkanen, K., Eriksson, K. S., Sallmen, T., Kalimo, H., & Relja, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00353-9 · Cited by 165
Guide to Receptors and Channels, 2nd edition (2007 Revision)
Alexander, S. P. H., Mathie, A., & Peters, J. A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707199 · Cited by 163
Winslow, J. T., & Camacho, F. (1995) · Psychopharmacology · doi:10.1007/bf02245626 · Cited by 156
Neurobiology of animal models of attention-deficit hyperactivity disorder
Russell, V. A. (2006) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.12.005 · Cited by 151
In vivo release of neuronal histamine in the hypothalamus of rats measured by microdialysis
Mochizuki, T., Yamatodani, A., Okakura, K., Takemura, M., Inagaki, N., & Wada, H. (1991) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168609 · Cited by 144
Acute wake‐promoting actions of JNJ‐5207852, a novel, diamine‐based H3 antagonist
Barbier, A., Berridge, C. W., Dugovic, C., Laposky, A. D., Wilson, S. J., Boggs, J. D., Aluisio, L. E., Lord, B., Mazur, C., Pudiak, C. M., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705964 · Cited by 144
Wieland, K., Bongers, G., Yamamoto, Y., Hashimoto, T., Yamatodani, A., Menge, W. M. P. B., Timmerman, H., Lovenberg, T. W., & Leurs, R. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29209-0 · Cited by 144
Central histaminergic system and cognition
Passani, M. B., Bacciottini, L., Mannaioni, P. F., & Blandina, P. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00053-6 · Cited by 143
Histamine H3 receptor antagonists: From target identification to drug leads
Bonaventure, P., Letavic, M. A., Dugovic, C., Wilson, S. M. B., Aluisio, L. E., Pudiak, C. M., Lord, B., Mazur, C., Kamme, F., Nishino, S., et al. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.10.031 · Cited by 134
Huston, J. P., Wagner, U. A. G., & Hasenöhrl, R. U. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)86052-4 · Cited by 134
Memory facilitation by histamine.
de Almeida, M. A. M. R., & Izquierdo, I. (1986) · PubMed · Cited by 134
Genomic organization and characterization of splice variants of the human histamine H3 receptor
Cogé, F., Guenin, S., Audinot, V., et al. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3550279 · Cited by 126
Cowart, M., Faghih, R., Curtis, M. P., Gfesser, G. A., Bennani, Y. L., Black, L. A., Pan, L., Marsh, K. C., Sullivan, J. P., Esbenshade, T. A., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040118g · Cited by 122
Self-citationInfluence of histamine depletion on learning and memory recollection in rats
KAMEI, C., Okumura, Y., & Tasaka, K. (1993) · Psychopharmacology · doi:10.1007/bf02244955 · Cited by 119
Histamine H3Receptors Inhibit Serotonin Release in Substantia Nigra Pars Reticulata
Threlfell, S., Cragg, S. J., Kalló, I., Turi, G. F., Coen, C. W., & Greenfield, S. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2690-04.2004 · Cited by 118
Gattu, M., Terry, A. V., Pauly, J. R., & Buccafusco, J. J. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00794-4 · Cited by 114
Meguro, K. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00248-u · Cited by 113
Fox, G. B., Pan, J. B., Esbenshade, T. A., Bennani, Y. L., Black, L. A., Faghih, R., Hancock, A. A., & Decker, M. W. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00379-5 · Cited by 111
Self-citationLigneau, X., Landais, L., Perrin, D., Piriou, J., Uguen, M., Denis, E., Robert, P., Parmentier, R., Anaclet, C., Lin, J., et al. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.023 · Cited by 110
Wellendorph, P., Goodman, M. W., Burstein, E. S., et al. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00041-2 · Cited by 104
Genetic and pharmacological aspects of histamine H3 receptor heterogeneity
Hancock, A. A., Esbenshade, T. A., Krueger, K. M., & Yao, B. B. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.06.003 · Cited by 104
Self-citationPassani, M. B., Cangioli, I., Baldi, E., Bucherelli, C., Mannaioni, P. F., & Blandina, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01780.x · Cited by 103
Anxiety and cognition in histamine H3 receptor−/− mice
Rizk‐Jackson, A., Curley, J., Robertson, J., & Raber, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03251.x · Cited by 102
Esbenshade, T. A., Krueger, K. M., Miller, T. R., Kang, C. H., Denny, L. I., Witte, D. G., Yao, B. B., Fox, G. B., Faghih, R., Bennani, Y. L., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047183 · Cited by 102
Self-citationGiovannini, M. G. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00063-7 · Cited by 98
Cangioli, I., Baldi, E., Mannaioni, P. F., Bucherelli, C., Blandina, P., & Passani, M. B. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02092.x · Cited by 96
Mazurkiewicz-Kwilecki, I. M., & Nsonwah, S. (1989) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y89-013 · Cited by 96
Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTPγ[S]binding to pertussis toxin
Clark, E. A., & Hill, S. J. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00800-4 · Cited by 95
Munzar, P., Tanda, G., Justinová, Z., & Goldberg, S. R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300380 · Cited by 94
Histamine function in brain disorders
Fernández‐Novoa, L., & Cacabelos, R. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00215-7 · Cited by 94
Histaminergic Modulation of Hippocampal Acetylcholine Release In Vivo
Mochizuki, T., Okakura‐Mochizuki, K., Horii, A., Yamamoto, Y., & Yamatodani, A. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62062275.x · Cited by 92
Characteristics of recombinantly expressed rat and human histamine H3 receptors
Wulff, B. S., Hastrup, S., & Rimvall, K. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02382-8 · Cited by 86
Brain histamine in Alzheimer's disease.
Cacabelos, R., Yamatodani, A., Niigawa, H., Hariguchi, S., Tada, K., Nishimura, T., Wada, H., Brandeis, L., & Pearson, J. (1989) · PubMed · Cited by 83
Day, M., Pan, J. B., Buckley, M. J., Cronin, E. A., Hollingsworth, P. R., Hirst, W. D., Navarra, R. L., Sullivan, J. P., Decker, M. W., & Fox, G. B. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.12.004 · Cited by 80
Characterization of perforant path lesions in rodent models of memory and attention
Kirkby, D. L., & Higgins, G. A. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00087.x · Cited by 74
Effects of histamine H3 receptor antagonists in two models of spatial learning
Komater, V. A., Buckley, M. J., Browman, K. E., Pan, J. B., Hancock, A. A., Decker, M. W., & Fox, G. B. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.11.008 · Cited by 70
Self-citationBakker, R. A., Lozada, A. F., van Marle, A., Shenton, F. C., Drutel, G., Karlstedt, K. A., Hoffmann, M., Lintunen, M., Yamamoto, Y., van Rijn, R. M., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.019299 · Cited by 70
Bacciottini, L., Passani, M. B., Giovannelli, L., Cangioli, I., Mannaioni, P. F., Schunack, W. G., & Blandina, P. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02005.x · Cited by 69
Terry, A. V., Hernandez, C. M., Buccafusco, J. J., & Gattu, M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00377-8 · Cited by 66
Perspectives on cognitive domains, H3receptor ligands and neurological disease
Hancock, A. A., & Fox, G. B. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.10.1237 · Cited by 66
Medhurst, A. D., Briggs, M. A., Bruton, G., Calver, A. R., Chessell, I. P., Crook, B., Davis, J. B., Davis, R. P., Foley, A., Heslop, T., et al. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.007 · Cited by 64
Chen, Z., Sugimoto, Y., & Kamei, C. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00128-8 · Cited by 63
Silver, R. B., Mackins, C. J., Smith, N. C. E., Korichneva, I. L., Lefkowitz, K., Lovenberg, T. W., & Levi, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051599198 · Cited by 61
Komater, V. A., Browman, K. E., Curzon, P., Hancock, A. A., Decker, M. W., & Fox, G. B. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1431-0 · Cited by 59
Self-citationBannerman, D. M., Lemaire, M., Yee, B. K., Iversen, S. D., Oswald, C., Good, M. A., & Rawlins, J. N. P. (2002) · Experimental Brain Research · doi:10.1007/s00221-001-0938-z · Cited by 57
Orsetti, M., Ferretti, C., Gamalero, S. R., & Ghi, P. (2001) · Psychopharmacology · doi:10.1007/s002130100892 · Cited by 54
Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex
Horner, W. E., Johnson, D. E., Schmidt, A. W., & Rollema, H. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.048 · Cited by 53
Bongers, G., Krueger, K. M., Miller, T. R., Baranowski, J. L., Estvander, B. R., Witte, D. G., Strakhova, M. I., van Meer, P., Bakker, R. A., Cowart, M., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127639 · Cited by 53
Self-citationBarbier, A., Aluisio, L. E., Lord, B., Qu, Y., Wilson, S. J., Boggs, J. D., Bonaventure, P., Miller, K. L., Fraser, I. C., Dvorak, L. K., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.08.009 · Cited by 45
Moreno‐Delgado, D., Torrent, A., Gómez-Ramírez, J., de Esch, I. J. P., Blanco, I., & Ortiz, J. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.010 · Cited by 45
Seyedi, N., Mackins, C. J., Machida, T., Reid, A. C., Silver, R. B., & Levi, R. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.072504 · Cited by 37
Rubio, S., Begega, A., Santín, L. J., & Arias, J. L. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00328-x · Cited by 37
Jia, F., Kato, M., Dai, H., Xu, A., Okuda, T., Sakurai, E., Okamura, N., Lovenberg, T. W., Barbier, A., Carruthers, N. I., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.09.017 · Cited by 35
Humbert‐Claude, M., Morisset‐Lopez, S., Gbahou, F., & Arrang, J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.006 · Cited by 32
Chen, Z. (2000) · PubMed · Cited by 24
Cenni, G., Cangioli, J., Yamatodani, A., Passani, M. B., Mannaioni, P. F., Felice, A. M. D., & Blandina, P. (2004) · Inflammation Research · doi:10.1007/s00011-003-0325-2 · Cited by 13
Central histaminergic system interactions and cognition
Blandina, P., & Passani, M. B. (2006) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7772-4_8 · Cited by 8
Esbenshade, T. A., Krueger, K. M., Yao, B. B., Witte, D. G., Estvander, B. R., Baranowski, J. L., Miller, T. R., & Hancock, A. A. (2006) · Inflammation Research · doi:10.1007/s00011-005-0035-z · Cited by 8
Self-citation(2000) · doi:10.1002/(sici)1098-1063(2000)10:1<47::aid-hipo5>3.0.co;2-6
Cited by
Talele, T. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00472 · Cited by 1,023
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
Panula, P., Chazot, P. L., Cowart, M., Gutzmer, R., Leurs, R., Liu, W. L. S., Stark, H., Thurmond, R. L., & Haas, H. L. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010249 · Cited by 575
Self-citationMiyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 573
Therapeutic strategies for Alzheimer's disease in clinical trials
Godyń, J., Jończyk, J., Panek, D., & Malawska, B. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2015.07.006 · Cited by 452
The histaminergic network in the brain: basic organization and role in disease
Panula, P., & Nuutinen, S. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3526 · Cited by 338
Metadata
- Authors
- Esbenshade, T. A., Browman, K. E., Bitner, R. S., Strakhova, M., Cowart, M. D., & Brioni, J. D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-07
- Volume
- 154
- Issue
- 6
- Pages
- 1166-1181
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1968695161
- Cited by
- 296
- References
- 83
- FWCI
- 10.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.